Literature DB >> 22573306

Differential distribution of diacylglycerol lipase-alpha and N-acylphosphatidylethanolamine-specific phospholipase d immunoreactivity in the superficial spinal dorsal horn of rats.

Zoltán Hegyi1, Krisztina Holló, Gréta Kis, Ken Mackie, Miklós Antal.   

Abstract

It is generally accepted that the endocannabinoid system plays important roles in spinal pain processing. Although it is documented that cannabinoid-1 receptors are strongly expressed in the superficial spinal dorsal horn, the cellular distribution of enzymes that can synthesize endocannabinoid ligands is less well studied. Thus, using immunocytochemical methods at the light and electron microscopic levels, we investigated the distribution of diacylglycerol lipase-alpha (DGL-α) and N-acylphosphatidylethanolamine-specific phospholipase D (NAPE-PLD), enzymes synthesizing the endocannabinoid ligands, 2-arachidonoylglycerol (2-AG) and anandamide, respectively. Positive labeling was revealed only occasionally in axon terminals, but dendrites displayed strong immunoreactivity for both enzymes. However, the dendritic localization of DGL-α and NAPE-PLD showed a remarkably different distribution. DGL-α immunolabeling in dentrites was always revealed at membrane compartments in close vicinity to synapses. In contrast to this, dendritic NAPE-PLD labeling was never observed in association with synaptic contacts. In addition to dendrites, a substantial proportion of astrocytic (immunoreactive for GFAP) and microglial (immunoreactive for CD11b) profiles were also immunolabeled for both DGL-α and NAPE-PLD. Glial processes immunostained for DGL-α were frequently found near to synapses in which the postsynaptic dendrite was immunoreactive for DGL-α, whereas NAPE-PLD immunoreactivity on glial profiles at the vicinity of synapses was only occasionally observed. Our results suggest that both neurons and glial cells can synthesize and release 2-AG and anandamide in the superficial spinal dorsal horn. The 2-AG can primarily be released by postsynaptic dendrites and glial processes adjacent to synapses, whereas anandamide can predominantly be released from nonsynaptic dendritic and glial compartments.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22573306      PMCID: PMC3703832          DOI: 10.1002/glia.22351

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  111 in total

1.  Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons.

Authors:  Zhongfeng Wang; Li Kai; Michelle Day; Jennifer Ronesi; Henry H Yin; Jun Ding; Tatiana Tkatch; David M Lovinger; D James Surmeier
Journal:  Neuron       Date:  2006-05-04       Impact factor: 17.173

2.  Molecular composition of the endocannabinoid system at glutamatergic synapses.

Authors:  István Katona; Gabriella M Urbán; Matthew Wallace; Catherine Ledent; Kwang-Mook Jung; Daniele Piomelli; Ken Mackie; Tamás F Freund
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

Review 3.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 4.  Astrocyte control of synaptic transmission and neurovascular coupling.

Authors:  Philip G Haydon; Giorgio Carmignoto
Journal:  Physiol Rev       Date:  2006-07       Impact factor: 37.312

5.  Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway.

Authors:  Gabriel M Simon; Benjamin F Cravatt
Journal:  J Biol Chem       Date:  2006-07-03       Impact factor: 5.157

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo.

Authors:  S Kelly; V Chapman
Journal:  J Neurophysiol       Date:  2001-12       Impact factor: 2.714

8.  Brain monoglyceride lipase participating in endocannabinoid inactivation.

Authors:  T P Dinh; D Carpenter; F M Leslie; T F Freund; I Katona; S L Sensi; S Kathuria; D Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

9.  Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2.

Authors:  A G Hohmann; K Tsou; J M Walker
Journal:  Neurosci Lett       Date:  1998-12-04       Impact factor: 3.046

Review 10.  Two isoforms of glutamate decarboxylase: why?

Authors:  J J Soghomonian; D L Martin
Journal:  Trends Pharmacol Sci       Date:  1998-12       Impact factor: 14.819

View more
  9 in total

1.  Peripheral inflammation affects modulation of nociceptive synaptic transmission in the spinal cord induced by N-arachidonoylphosphatidylethanolamine.

Authors:  Vladimir Nerandzic; Petra Mrozkova; Pavel Adamek; Diana Spicarova; Istvan Nagy; Jiri Palecek
Journal:  Br J Pharmacol       Date:  2017-06-11       Impact factor: 8.739

2.  Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain.

Authors:  Emma Leishman; Ken Mackie; Serge Luquet; Heather B Bradshaw
Journal:  Biochim Biophys Acta       Date:  2016-03-05

Review 3.  Endocannabinoid signaling and synaptic function.

Authors:  Pablo E Castillo; Thomas J Younts; Andrés E Chávez; Yuki Hashimotodani
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

4.  Subcellular localization of NAPE-PLD and DAGL-α in the ventromedial nucleus of the hypothalamus by a preembedding immunogold method.

Authors:  Leire Reguero; Nagore Puente; Izaskun Elezgarai; Almudena Ramos-Uriarte; Inmaculada Gerrikagoitia; José-Luis Bueno-López; Francisco Doñate; Pedro Grandes
Journal:  Histochem Cell Biol       Date:  2013-12-18       Impact factor: 4.304

Review 5.  Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection.

Authors:  Sandeep Vasant More; Dong-Kug Choi
Journal:  Mol Neurodegener       Date:  2015-04-08       Impact factor: 14.195

Review 6.  Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.

Authors:  Mariana Babayeva; Haregewein Assefa; Paramita Basu; Sanjeda Chumki; Zvi Loewy
Journal:  Parkinsons Dis       Date:  2016-12-05

Review 7.  The Endocannabinoid System and Invertebrate Neurodevelopment and Regeneration.

Authors:  Tristyn L Clarke; Rachael L Johnson; Jonathan J Simone; Robert L Carlone
Journal:  Int J Mol Sci       Date:  2021-02-20       Impact factor: 5.923

8.  CB1 receptor activation induces intracellular Ca2+ mobilization and 2-arachidonoylglycerol release in rodent spinal cord astrocytes.

Authors:  Zoltán Hegyi; Tamás Oláh; Áron Kőszeghy; Fabiana Piscitelli; Krisztina Holló; Balázs Pál; László Csernoch; Vincenzo Di Marzo; Miklós Antal
Journal:  Sci Rep       Date:  2018-07-12       Impact factor: 4.379

9.  Differential expression of Na+/K+/Cl- cotransporter 1 in neurons and glial cells within the superficial spinal dorsal horn of rodents.

Authors:  Fariba Javdani; Krisztina Hegedűs; Camila Oliveira Miranda; Zoltán Hegyi; Krisztina Holló; Miklós Antal
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.